Sarvear Pharmaceuticals UA, which came into existence in 1971 and has emerged as a preferred contract manufacturer for Finished Formulations and Drug Intermediate making its presence across the country and tapping global markets as well.
Sarvear Group is taken care by Experienced and Tecnocrat Directors and their temperament do get reflected in the products being manufactured by us and for the same reason we have been approved vendors of Glaxo Smithkline Ltd GSK , Wyethe Ledrle and German Remedies for drug intermediates.
Sarvear Pharmaceuticals U.A is subsidiary of Sarvear group and has State of Art manufacturing Facilty for Beta lactam Dry injection , in House fully loaded Quality Control lab and most experienced Quality Assurance team. The company has already achieved Schedule M –GMP certificate and ISO and gearing up for WHO GMP . With its Inception in 2007, barely 7-8 years back we have become one of the most trusted and cheered manufacturer of Beta lactum Dry injection in Domestic market and has made several African and CIS countries addicted to its quality policy.
Symparlife Sciences is the Marketing Division of Sarvear UA being launched in the year 2014 and is emerging and is being accepted as fast growing Pharmaceutical Company. With a portfolio of more than 100 products in its basket caters to the needs of Channel / Franchises Partners.
We are committed to long term relationship with our Clients , Channel/ Franchise Partners as Ethics and approach to achieve highest is the prime focus of the Group.
Our mission is to establish ourselves as one of the most intellectual , quality conscious manufacturer of injectables in Indian and International market with the help of most advanced technological skills , Ethics and Human values. Our Mission is to provide Best possible quality Medicine for a disease free world .
Sarvear Group is preferred vendor of Drug intermediates and finished formulations for renowned companies in India as well as Africa and Latin America